IQWIG not bullish on EMAs adaptive pathways pilot

Hi All,

just saw an interesting post (https://www.iqwig.de/en/press/press-releases/press-releases/adaptive-pathways-ema-still-leaves-open-questions-unanswered.7492.html) from IQWIG, that speaks to the difficulties to get even a clinical effectiveness assessment under one roof as always proposed by various stakeholders. Clearly the RWE bit is still an open book in many ways but a topic to be tackled on various fronts in order to make true value based pricing a reality.